CXA Celoxica

RNS Number:6211F
Celoxica Holdings PLC
12 October 2007


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1.  Identity of the issuer or the underlying issuer of existing shares to
    which voting rights are attached
    CELOXICA HOLDINGS PLC

2.  Reason for the notification (please tick the appropriate box or boxes)

    An acquisition or disposal of voting rights                       (X)

    An acquisition or disposal of financial instruments which may     ( )
    result in the acquisition of shares already issued to which
    voting rights are attached

    An event changing the breakdown of voting rights                  ( )

    Other (specify):                                                  ( )

3.  Full name of person(s) subject to the notification obligation:
    Advent Venture Partners LLP

4.  Full name of shareholder(s) (if different from 3.)
    (NB abbreviation noted in brackets)

    Advent Private Equity Fund III 'A' (APEF3A);
    Advent Private Equity Fund III 'B' (APEF3B);
    Advent Private Equity Fund III 'C' (APEF3C);
    Advent Private Equity Fund III 'D' (APEF3D);
    Advent Private Equity Fund III GmbH & Co KG (APEF3KG);
    Advent Private Equity Fund III Affiliates (APEF3Aff);
    Advent Management III Limited Partnership (AM3LP)

5.  Date of the transaction (and date on which the threshold is crossed
    or reached if different):
    10 Oct 2007

6.  Date on which issuer notified:
    11 Oct 2007

7.  Threshold(s) that is/are crossed or reached:
    24 %

8.  Notified details:

A. Voting rights attached to shares

Class/type of shares (if possible using the            Ordinary (GB00B0L9TZ33)
ISIN code)

Situation previous to  Resulting situation after the triggering transaction
the triggering
transaction
Number of     Number   Number     Number of voting       % of voting rights
Shares        of       of         rights
              Voting   shares
              Rights
                       Direct     Direct   Indirect      Direct    Indirect
20,735,553*                                20,735,553*             24.594%*
*: comprised                               *: comprised            *: comprised 
of                                         of                      of:
                                                             
APEF3A:                                    APEF3A:                 APEF3A: 
10,492,939                                 10,492,939              12.446%
                                       
APEF3B:                                    APEF3B:                 APEF3B:
5,141,609                                  5,141,609               6.099%
                                       
APEF3C:
1,434,234                                  APEF3C:                 APEF3C:
                                           1,434,234               1.701%
APEF3D:
2,821,118                                  APEF3D:                 APEF3D:
                                           2,821,118               3.346%

APEF3KG:                                   APEF3KG:                APEF3KG:  
405,914                                    405,914                 0.481%

APEF3Aff:                                  APEF3Aff:               APEF3Aff:                
338,263                                    338,263                 0.401%
                                       
AM3LP:                                     AM3LP:                  AM3LP:
101,476                                    101,476                 0.120%
        

B. Financial Instruments

Resulting situation after the triggering transaction
Type of       Expiration   Exercise/          Number of voting  % of voting
financial     date         Conversion Period/ rights that may   rights
instrument                 Date               be acquired if
                                              the instrument is
                                              exercised/
                                              converted
n/a



Total (A+B)
Number of voting rights              % of voting rights
Refer A above

9.  Chain of controlled undertakings through which the voting rights and/
    or the financial instruments are effectively held, if applicable:

    Advent Venture Partners LLP owns 100% of Advent Limited. Advent
    Limited owns 100% of Advent Private Equity GmbH, which is the general
    partner of Advent Private Equity Fund III GMBH & CO KG. Advent
    Limited also owns 100% of Advent Management III Limited, which is the
    general partner of Advent Management III Limited Partnership, which
    is general partner of each of Advent Private Equity Fund III 'A'
    Limited Partnership, Advent Private Equity Fund III 'B' Limited
    Partnership, Advent Private Equity Fund III 'C' Limited Partnership,
    Advent Private Equity Fund III 'D' Limited Partnership and Advent
    Private Equity Fund III Affiliates Limited Partnership.


Proxy Voting:
10.  Name of the proxy holder:

11.  Number of voting rights proxy
     holder will cease to hold:

12.  Date on which proxy holder
     will cease to hold voting
     rights:

13.  Additional information:

14:  Contact name:                    Leslie Gabb, Finance Partner

15.  Contact telephone number:        +44 20 7932 2100




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLGUGPCUUPMGUP

Celoxica (LSE:CXA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Celoxica (LSE:CXA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024